Lv3
242 积分 2025-10-11 加入
Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium–glucose co‐transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus
17天前
已完结
Pharmacokinetics of chlorpromazine and key metabolites
1个月前
已完结
Abstract CT063: First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies (NCT04886622)
4个月前
已完结
Phase separation of p62: roles and regulations in autophagy
4个月前
已完结
Chaperone‐Mediated Autophagy in Aging and Disease
4个月前
已完结
Chaperone‐Mediated Autophagy in Aging and Disease
4个月前
已关闭
Chaperone‐Mediated Autophagy in Aging and Disease
4个月前
已关闭
Chaperone‐Mediated Autophagy in Aging and Disease
4个月前
已关闭
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
4个月前
已完结
Aptamer‐LYTACs for Targeted Degradation of Extracellular and Membrane Proteins
4个月前
已完结
皖公网安备34019202002308
